News
Press Releases
Additional Press Releases
Cardiac Dimensions Announces $17.5 Million Series C Financing to Accelerate Sales Expansion of the Carillon Mitral Contour System® September 29, 2020
Cardiac Dimensions Announces Australian Therapeutic Goods Administration’s Approval of the Carillon System for the Treatment of Functional Mitral Regurgitation September 2, 2020
Cardiac Dimensions Hires Gretchen Gary as Vice President of Global Therapy Development March 6, 2020
New Data Confirms Cardiac Dimensions’ Carillon System Shows Favorable Long-Term Survival Rate in Patients with Functional Mitral Regurgitation February 25, 2020
The 2021 ESC guidelines for #heartfailure management introduced “other percutaneous therapies” which includes the #Carillon Mitral Contour System® as the only other non-TEER Class IIb option in the treatment of SMR. Learn more: https://t.co/be25fjZJKu https://t.co/o8ugg9eMzf
Join us at eSPACE Heart Failure 2021 presented by Translational Medicine Academy in Session 9, which will focus on valvular #heartdisease in #heartfailure. Prof. Dr. med. Horst Sievert will present on “Mitral valve disease—Focus on Carillon”. Register now: https://t.co/ovDfIgNTr9 https://t.co/a7lvYGyjvj
Being informed of our heart health is one of the easiest ways to prevent heart diseases such as FMR and #heartfailure. With this knowledge, we can feel empowered to make informed decisions to take care of your heart. Get involved this #WorldHeartDay: https://t.co/6py5dwaUrg https://t.co/OqMmJYb9sL
